Comprehensive Study Notes on Genetic Disorders
Key Terminology in Genetics
- DNA (Deoxyribonucleic Acid): The double-stranded nucleic acid molecule located primarily in the cell nucleus that carries the master genetic instructions for living organisms.
- Gene: A specific sequence of DNA nucleotides that contains the precise code for synthesizing a functional protein or enzyme.
- RNA (Ribonucleic Acid): Single-stranded nucleic acid synthesized from DNA that acts as an intermediary messenger and functional worker in protein assembly within the cytoplasm.
- Genotype: The complete genetic constitution and specific allele composition of an individual organism.
- Phenotype: The observable physical, physiological, or biochemical characteristics of an individual resulting from the interaction of its genotype with the environment.
- Homozygous: Possessing two identical alleles at a specific locus on homologous chromosomes.
- Heterozygous: Possessing two different alleles at a specific locus on homologous chromosomes.
- Dominant: An allele or trait that expresses its phenotypic effect even when present in the heterozygous state, masking the recessive allele.
- Recessive: An allele or trait that is phenotypically expressed only when present in the homozygous state.
- Autosomal Dominant: A pattern of inheritance in which a single copy of a mutated gene on a non-sex chromosome is sufficient to cause the phenotype or disorder.
- Autosomal Recessive: A pattern of inheritance requiring two copies of a mutated gene on a non-sex chromosome (one from each parent) for the phenotype or disorder to be expressed.
- X-Linked: A pattern of inheritance caused by gene mutations located on the X chromosome.
- Microcephaly: A neurodevelopmental condition characterized by a significantly abnormally small head circumference relative to age and sex.
- Macroorchidism: Abnormal bilateral enlargement of the testicles, commonly observed post-puberty in males with Fragile X syndrome.
Foundations of the Human Genome
- The Human Genome Project:
- A landmark international scientific research project conducted from 1990 to 2003.
- Successfully mapped and sequenced the entire human genome.
- Identified direct causal links between thousands of clinical diseases and specific mutated genes.
- Paved the way for the clinical field of pharmacogenomics, enabling targeted gene-based therapeutic interventions.
Cellular Mechanisms of Genetic Control
- Mechanisms of Genetic Control:
- Genetic control within cells is directly mediated by DNA.
- DNA is composed of individual structural and functional units called genes.
- Genes encode explicit chemical instructions required for producing all cellular proteins and enzymes.
- Characteristics and Behavior of DNA:
- The vast majority of cellular DNA resides securely inside the nucleus.
- Every somatic cell in the body carries the complete set of genetic information inherited from the original gametes (the ovum and sperm).
- DNA must undergo precise duplication and separation prior to the cell entering mitosis.
- Structurally forms a double-stranded helix resembling a twisted ladder.
- Un-repaired damage to DNA code directly leads to cellular dysfunction, mutation, and disease.
- Characteristics and Behavior of RNA:
- RNA molecules are directly transcribed from active DNA template strands.
- RNA translocates out of the nucleus to function within the cellular cytoplasm.
- It binds and transports essential amino acids necessary for building protein chains.
- Carries precise sequence directions for assembling amino acids into polypeptides.
- Provides both the structural machinery (ribosomes) and physical cytoplasmic location for protein synthesis.
Chromosomal Architecture and Cell Division
- Gene Dynamics:
- Human cells contain approximately 23,000 individual genes.
- The complete baseline set of 23,000 genes is identical across every cell in an individual's body.
- Not all genes are active or expressed in every cell; selective gene expression dictates cell specialization.
- Mutations occur primarily during DNA replication and duplication.
- The ultimate functional effect of a mutation depends heavily on the timing of when the mutation occurs during cell development or organism life cycle.
- Multiple genes are linked together sequentially to form visible linear structures called chromosomes.
- Chromosomal Architecture:
- Chromosomes physically package and store genetic information generated by DNA and RNA processes.
- Arranged in homologous pairs (one chromosome derived from the mother and one from the father) in every somatic nucleus.
- Possess a highly organized structural anatomy.
- Human cells contain 23 pairs of chromosomes (46 total chromosomes):
- 22 pairs are autosomes (non-sex-determining chromosomes).
- 1 pair comprises the sex chromosomes.
- Sex chromosome structural differences:
- Females carry two X chromosomes (XX).
- Males carry one X chromosome and one Y chromosome (XY).
- Alleles: Corresponding, matching gene pairs located at identical positions on homologous chromosomes.
- Karyotype: A standardized photomicrograph image displaying all 23 pairs of human chromosomes ordered by size, shape, and banding pattern.
- Comparison of Cell Division Pathways:
- Mitosis:
- Initiates with chromosome replication.
- Chromosomes line up along the equatorial spindle apparatus.
- Executes a single cell division event producing two genetically identical diploid daughter cells.
- Meiosis:
- Occurs exclusively in germ line cells to produce gametes.
- Paternal and maternal homologous chromosomes undergo replication.
- Homologous chromosomes undergo physical pairing and genetic crossover (recombination).
- Paired chromosomes align on the spindle apparatus.
- Undergoes a first meiotic division (Meiosis I), separating homologous pairs.
- Undergoes a second meiotic division (Meiosis II), separating sister chromatids to produce four unique haploid gametes.
Gene Regulation, Somatic vs. Germline Mutation, and Bioengineering
- Gene Regulation:
- Every somatic cell possesses the organism's complete genomic DNA sequence.
- Cellular differentiation occurs because only active genes are expressed in specific tissue types.
- Mutations represent direct structural alterations or damage to the genetic code sequence.
- Somatic Cell Mutations: Damage occurring in non-reproductive body cells causes acquired disease (such as neoplasia) in that specific individual, but cannot be transmitted to offspring.
- Germ Cell Mutations: Damage occurring within gamete cells (sperm or ovum) is inheritable and passed directly down to future generations.
- Recombinant DNA Technology:
- Cleavage: Target double-stranded DNA is split using specific restriction enzymes.
- Modification: Target DNA sequences may be artificially altered, edited, or synthesized.
- Insertion: The modified DNA sequence is inserted into a single-celled host organism (such as a plasmid vector within a bacterium).
- Replication: The transgenic single-celled host organism replicates, cloning the inserted DNA sequence across cell generations.
- Extraction: The synthesized recombinant protein product or replicated gene code is extracted and purified for medical or industrial use.
Patterns of Genetic Pathology, Penetrance, and Expressivity
- Genetic versus Congenital Etiology:
- Congenital: Defines any physical defect or clinical condition present at birth, regardless of whether the root cause is genetic, environmental, or developmental.
- Genetic: Defines pathology arising directly from an inherited or spontaneous DNA gene mutation, which may or may not manifest physically at the time of birth.
- Penetrance and Expressivity:
- Penetrance: The mathematical probability or likelihood that an individual carrying a specific mutated genotype will actually manifest the corresponding clinical phenotype.
- Example: For an individual inheriting a mutated gene for colon cancer, penetrance represents the quantitative likelihood that they will clinically develop colon cancer in their lifetime.
- Expressivity: The variation or degree of clinical severity with which a specific phenotype is expressed in an individual.
- Example: For an individual inheriting the gene for hypercholesterolemia, expressivity dictates the actual quantitative magnitude of serum cholesterol elevation.
Sex-Linked Inheritance and Fragile X Syndrome
- X-Linked Inheritance Dynamics:
- X-linked recessive disorders predominantly affect male offspring because males (XY) lack a second, balancing X chromosome to offset a defective gene allele.
- Affected fathers pass the mutant X-linked gene to 100% of their daughters (making them carriers or affected) and 0% of their sons (since sons inherit only the father's Y chromosome).
- Carrier mothers carrying one mutant X chromosome have:
- A 1 in 2 (50%) chance of producing an affected male child per pregnancy.
- A 1 in 2 (50%) chance of producing a carrier female child per pregnancy.
- Females rarely express full X-linked disease phenotypes, as manifestation requires inheriting two defective X chromosomes (one from an affected father and one from a carrier or affected mother).
- Fragile X Syndrome:
- Etiology: Caused by a mutation in the FMR1 gene located on the X chromosome.
- Epidemiology: Represents the single most common inherited cause of cognitive impairment in humans. Occurs in 1 in 1,550 male births and 1 in 8,000 female births.
- Neurobehavioral Manifestations: Mental retardation ranging from subtle learning deficits to severe impairment; pronounced autistic-like behaviors including extreme shyness, avoidance of eye contact, and marked attention deficits.
- Craniofacial Features: Elongated facial structure with a prominent, large mandible, and large, everted ears.
- Reproductive Features: Post-pubertal macroorchidism (abnormally enlarged testicles).
- Cardiovascular & Musculoskeletal Features: Mitral valve prolapse and hyperextensible, hypermobile joints.
Autosomal Dominant Disorders
- Inheritance Probabilities:
- Requires only a single mutant dominant allele (A) to produce disease phenotype.
- Mating between one affected heterozygous parent (Aa) and one unaffected parent (aa):
- 50% probability (Aa) of producing affected offspring.
- 50% probability (aa) of producing unaffected homozygous normal offspring.
- Mating between two affected heterozygous parents (both Aa):
- 75% probability (AA or Aa) of producing affected offspring.
- 25% probability (aa) of producing unaffected homozygous normal offspring.
- Marfan Syndrome:
- Pathophysiology: Autosomal dominant connective tissue disorder affecting systemic connective matrices, primary affecting skeletal, ocular, cardiovascular, and central nervous systems.
- Skeletal Features: Exaggerated, long, thin extremities; long slender fingers (arachnodactyly); hyperflexible joints; structural chest deformities including pectus excavatum (sunken sternum) or protruding sternum; long narrow facial structure; micrognathia (small jaw); severe dental overcrowding.
- Ocular Features: Bilateral dislocation of the lens (ectopia lentis), severe myopia, and high predisposition to retinal detachment.
- Cardiovascular Features: Valvular structural abnormalities, progressive root dilation of the aorta, aortic aneurysm formation, and fatal aortic rupture.
- Nervous System Features: Dural ectasia (pathological enlargement or expansion of the dura mater surrounding the spinal cord).
- Huntington Disease:
- Pathophysiology: Autosomal dominant neurodegenerative condition causing delayed, progressive neurological decline.
- Onset: Clinical symptoms characteristically manifest late in life, typically around 35 to 40 years of age.
- Clinical Presentation: Severe progressive mental deterioration paired with involuntary, uncoordinated choreiform movements of the arms and legs.
- Prognosis: Uniformly fatal condition, typically resulting in death approximately 20 years following clinical onset (around 55 years of age).
Autosomal Recessive Disorders
- Inheritance Dynamics:
- Requires two copies of the mutant allele (aa)—one inherited from each parent—to express the abnormal phenotype.
- Heterozygous individuals (Aa) carry the gene silently and remain clinically asymptomatic.
- Phenylketonuria (PKU):
- Pathophysiology: Metabolic defect caused by the total deficiency of an enzyme required to breakdown phenylalanine into non-toxic metabolites, leading to toxic accumulation.
- Clinical Presentation: Causes slow-onset, progressive mental retardation, microcephaly, and delayed speech development.
- Screening: Mandatory universal screening via heel-stick blood testing administered to all neonates prior to hospital discharge.
- Therapeutic Management: Requires strict lifelong dietary modification, strictly avoiding dietary protein, dairy products, and artificial sweeteners containing aspartame.
- Tay-Sachs Disease:
- Pathophysiology: Absence of a crucial lysosomal lipid-metabolizing enzyme, leading to progressive, massive lipid accumulation within central nervous system tissues and subsequent destruction/displacement of neural cells.
- Epidemiology: Highest prevalence occurs among individuals of Ashkenazi Jewish ancestry.
- Clinical Course: Infants appear completely normal for the first few months of life, followed by rapid, relentless neurological decline.
- Pathognomonic Sign: A distinctive